Inhibitory mechanism of Empagliflozin on renal clear cell adeno carcinoma through downregulation of nuclear YAP/BRD4-mediated epithelial-mesenchymal transition via activation of the AMPK/PTEN/HDAC11 pathway

Inhibitory mechanism of Empagliflozin on renal clear cell adeno carcinoma through downregulation of nuclear YAP/BRD4-mediated epithelial-mesenchymal transition via activation of the AMPK/PTEN/HDAC11 pathway

Chinese Journal of Anatomy ›› 2025, Vol. 48 ›› Issue (2) : 154-160.

Chinese Journal of Anatomy ›› 2025, Vol. 48 ›› Issue (2) : 154-160. DOI: 10.3969/j.issn.1001-1633.2025.02.012

Inhibitory mechanism of Empagliflozin on renal clear cell adeno carcinoma through downregulation of nuclear YAP/BRD4-mediated epithelial-mesenchymal transition via activation of the AMPK/PTEN/HDAC11 pathway

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 48(2): 154-160 https://doi.org/10.3969/j.issn.1001-1633.2025.02.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉